NCT05922384View on ClinicalTrials.gov

Safety and Efficacy Study of KL-7SHRNA Injection Solution in the Treatment of AIDS Patients With Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

September 10, 2025

Study Completion Date

April 10, 2026

Conditions
HIV InfectionsLymphoma
Interventions
DRUG

KL-7SHRNA injection solution

Patients continue to receive HAART throughout treatment until meet the criteria of interruption of HAART.

Trial Locations (1)

524001

RECRUITING

Affiliated hospital of Guangdong medical university, Zhanjiang

All Listed Sponsors
lead

Affiliated Hospital of Guangdong Medical University

OTHER